Retatrutide vs Tirzepatide vs Semaglutide Three compounds dominate current GLP-1-class research conversation: semaglutide (single agonist), tirzepatide (dual agonist), and retatrutide (triple agonist)
Yes, kids can use semaglutide injections, specifically adolescents aged 12 and older with obesity for weight management, alongside lifestyle changes, but it requires strict medical supervision and a doctors prescription due to potential side effects
Here are several advantages that our clients might experience: Improved Blood Sugar Control : For our clients with type 2 diabetes, semaglutide helps in maintaining a more stable blood glucose level
Wegovy (semaglutide) is a GLP-1 receptor agonist licensed for weight management, whilst Forxiga (dapagliflozin) is an SGLT2 inhibitor primarily used for type 2 diabetes, heart failure, and chronic kidney disease